BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/15/2023 3:50:16 PM | Browse: 53 | Download: 99
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 86605
Country/Territory China
2023-07-06 07:09
Peer-Review Started
2023-07-06 07:11
To Make the First Decision
Return for Revision
2023-09-05 20:03
2023-09-15 09:37
Second Decision
2023-09-28 02:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-09-28 05:55
Articles in Press
2023-09-28 05:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-11-03 08:21
Publish the Manuscript Online
2023-11-15 13:46
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature
Manuscript Source Unsolicited Manuscript
All Author List Wen-Hui Luo, Shao-Jun Li and Xue-Feng Wang
Funding Agency and Grant Number
Corresponding Author Xue-Feng Wang, MD, Associate Chief Physician, Doctor, The Second Department of Hepatobiliary Surgery, Yantai Yuhuangding Hospital, No. 20 Yuhuangding East Road, Zhifu District, Yantai 264000, Shandong Province, China. seasonslo@126.com
Key Words Cholangiocarcinoma; Immune-checkpoint-inhibitor; Lenvatinib; Sintilimab; Epigastric metastasis; Immunotherapy; Case report
Core Tip Cholangiocarcinoma (CCA) is a highly lethal hepatobiliary neoplasm. This report presents a case with advanced CCA who received immunotherapy, revealing differences in treatment responses between intrahepatic vs. extrahepatic epigastric metastatic sites. This hitherto unreported phenomenon prompted us to investigate the differential outcomes of these metastatic patterns following treatment with lenvatinib combined with sintilimab, culminating in a summary report elucidating potential underlying mechanisms.
Publish Date 2023-11-15 13:46
Citation Luo WH, Li SJ, Wang XF. Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature. World J Gastrointest Oncol 2023; 15(11): 2033-2040
URL https://www.wjgnet.com/1948-5204/full/v15/i11/2033.htm
DOI https://dx.doi.org/10.4251/wjgo.v15.i11.2033
Full Article (PDF) WJGO-15-2033-with-cover.pdf
Full Article (Word) WJGO-15-2033.docx
CARE Checklist–2016 86605-CARE Checklist (2016).pdf
Manuscript File 86605_Auto_Edited-JLW.docx
Answering Reviewers 86605-Answering reviewers.pdf
Audio Core Tip 86605-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 86605-Conflict-of-interest statement.pdf
Copyright License Agreement 86605-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s) 86605-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 86605-Language certificate.pdf
Peer-review Report 86605-Peer-review(s).pdf
Scientific Misconduct Check 86605-Bing-Qu XL-2.jpg
Scientific Editor Work List 86605-Scientific editor work list.pdf